(Q45073859)

9 December 2017

title

Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study (English)

1 reference

9 December 2017

Wim G Goettsch

1

1 reference

9 December 2017

Guido van den Boom

2

1 reference

9 December 2017

Nancy S Breekveldt-Postma

3

1 reference

9 December 2017

André J P M Smout

4

1 reference

9 December 2017

Ron M C Herings

5

1 reference

9 December 2017

publication date

1 November 2004

1 reference

Pharmacoepidemiology and Drug Safety

9 December 2017

published in

1 reference

9 December 2017

volume

13

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

803-810

1 reference

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPDS.997

Crossref

reference URL

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPDS.997

Crossref

reference URL

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPDS.997

Crossref

reference URL

21 January 2018

Identifiers

DOI

10.1002/PDS.997

1 reference

9 December 2017

1 reference